Novel Heterocyclic Compounds as Bromodomain Inhibitors
申请人:Liu Shuang
公开号:US20140179648A1
公开(公告)日:2014-06-26
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
申请人:GENENTECH, INC.
公开号:US20150322002A1
公开(公告)日:2015-11-12
The invention provides novel compounds having the general formula (I) and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X
2
, L, subscript m, X
1
, ring D, R
1
, and R
N
have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS
申请人:Zenith Epigenetics Ltd.
公开号:US20170143731A1
公开(公告)日:2017-05-25
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
GCN2 INHIBITORS AND USES THEREOF
申请人:Merck Patent GmbH
公开号:US20220340577A1
公开(公告)日:2022-10-27
The present invention provides compounds, compositions thereof, and methods of using the same.